PD-L1 anticorps (AA 18-227)
Aperçu rapide pour PD-L1 anticorps (AA 18-227) (ABIN5027434)
Antigène
Voir toutes PD-L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 18-227
-
Purification
- Protein G Chromatography
-
Immunogène
- A partial length recombinant PDL1 protein (amino acids 18-227) was used as the immunogen for this antibody.
-
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
- WB: 0.5-1 μg/mL, IHC-5-10 μg/mL, FACS: 1-2 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS containing 0.05 % BSA, PH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- PDL1
-
Sujet
- PD-L1 (CD274/B7-H1) is a critical membrane-bound costimulatory molecule belongs to the B7 superfamily that inhibits immune responses through its receptor, PD-1 and PD-L1 play a key role in the pathogenesis of inflammatory diseases (programmed death 1). It is widely expressed in the mononuclear phagocyte system (MPS), may co-stimulate T cells and regulates inflammatory responses. PD-L1 exerts inflammation regulatory functions via a negative co-stimulatory effect on T cell functions to inhibit cytokine secretion, facilitate apoptosis of activated T cells and induce T cell anergy. Aberrant expression and dysregulation of CD274 have been reported during bacterial infection, inflammation and in numerous autoimmune diseases.
-
Poids moléculaire
- 19 kDa
-
ID gène
- 29126
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-